Obesity and Muscle Signaling After a Single Workout and Protein Drink
Official title: Understanding the Effects of Obesity on Autophagic and mTORC1 Signalling Following Resistance Exercise and Protein Ingestion in Skeletal Muscle.
Run by University of Birmingham · NCT07774676 · Data updated 2026-11-12
This study tests whether skeletal muscle signaling after resistance exercise and protein intake differs between lean adults and those who are overweight or obese.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | All |
| Enrollment | 24 (estimated) |
| Sponsor | University of Birmingham Academic / other |
| Locations | 1 site (Birmingham) |
| Status | Recruiting |
| Started | April 15, 2026 |
| Main results expected | December 2026 |
| Study ends | December 2027 |
| Registry record updated | August 19, 2026 |
| Trial ID | NCT07774676 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 18-45 with lean BMI (18.5-24.9) or BMI >28, who are physically active but not currently in structured exercise programs.
✕Probably not a fit
Individuals with obesity who are on certain medications or have conditions listed in the exclusion criteria may not experience direct benefits from the study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will compare how skeletal muscle responds to a bout of single-leg resistance exercise and a protein-rich drink in two groups: lean adults and adults with overweight or obesity. Participants will provide muscle samples from both legs before and after the activities to analyze signaling pathways related to muscle growth and autophagy. The study uses muscle biopsies, blood samples, a protein beverage, a resistance exercise session, and body composition assessments to understand group differences. Results may help tailor strategies to improve muscle quality in obesity. The project is conducted at the University of Birmingham with healthy adults in the defined age range and BMI categories.
Why it matters
Potential benefit: If successful, findings could inform targeted approaches to enhance muscle growth and metabolic health in people with obesity.
How similar studies have gone: Prior studies suggest obesity can alter muscle signaling after exercise, but direct single-leg, within-subject comparisons with paired proteomic analyses are relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age - 18-45yrs * BMI - 18.5-24.9kg/m2 OR \>28kg/m2 (self-declaration, or calculated by research team based on height and weight) * Weight Stable i.e. no change in weight of more than 5% in previous 6 months * Meeting UK Physical activity guidelines (150 mins moderate or 75 mins vigorous activity/wk) * Not involved in structured exercise training in previous 6 months * No other diagnosed metabolic or neuromuscular conditions (self-declaration) Exclusion Criteria: * Currently using anti-diabetes medication (insulin, metformin, sulphonylureas, meglitinides, thiazolidinediones, DPP- 4 inhibitors, GLP-1 inhibitors). * Currently taking cholesterol lowering medications (statins) * Currently engaged in active weight loss programmes or using weight loss medication * Chronic kidney disease (moderate to severe reduction in kidney function), defined as eGFR \<30 ml/min/1.73m2 identified by self declaration. * Pregnant or breast feeding * Currently using anti-coagulation medication * Hypothyroidism * Type 1 diabetes * Current or recent weakness/injury to either leg that may affect muscle function or ability to exercise * Current gastrointestinal issue/condition that may affect digestion and absorption of protein drink * Individuals who follow a vegan diet or have intolerance/allergies to Whey protein. * Previous adverse reaction to local anaethetic (lidocaine or marcaine).
Where it's running
-
School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham
Birmingham, United Kingdom Recruiting
Study contacts
- Principal investigator: Nathan Hodson — University of Birmingham
- Study coordinator: Jennifer Barrett, PhD
- Email: j.s.barrett@bham.ac.uk
- Phone: +447875713844
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ZP6590 safety and dosing in adults with varying weight
This study tests ZP6590 in adults with normal weight, overweight, and obesity to see if it is safe and tolerable and to understand how the drug behaves in the body.
-
Eatit digital program to help adults with obesity lose weight and improve eating habits
This pilot will see if using Eatit's six-month, dietitian-supported digital lifestyle program helps adults with obesity lose weight, reduce waist size, and improve eating habits and self-rated health.
-
Plant-based, online weight loss program with education and support
A 12-week online program tests whether a plant-based diet, guided by a physician and a dietitian, can help overweight or obese adults improve weight, blood sugar, and cholesterol.
-
How sex hormones affect the age- and sex-related benefits of a low-calorie diet
This trial tests whether sex hormones explain why adults of different ages and sexes lose fat and get different health benefits when they follow a low-calorie diet.
-
Comparing the effects of high-intensity and moderate-intensity exercise on fat loss in young women
This study tests whether high-intensity or moderate-intensity exercise helps young women with overweight or obesity lose more fat and improve their health.
-
Identifying Malnutrition in Overweight Adults
This study is trying to see if overweight adults can also be malnourished, especially those affected by COVID-19, and will create a simple tool to help doctors spot malnutrition in these patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.